EQT’s Skincare Firm Galderma Sets Terms for $2.6 Billion IPO
- Galderma sets IPO price range at 49 to 53 Swiss francs apiece
- Firm’s market value could be up to 12.6 billion Swiss francs
Galderma’s skincare offering is led by Cetaphil.
Photographer: Alex Tai/SOPA Images/Getty ImagesThis article is for subscribers only.
Skincare company Galderma Group AG set the price range for a 2.3 billion Swiss-franc ($2.6 billion) initial public offering, in what would be the largest listing in Europe since that of Porsche AG in 2022.
The shares are being marketed at 49 to 53 Swiss francs apiece through March 20, the EQT AB-backed company said in a statement, with the stock set to start trading two days later. Based on the offer price range, Galderma will have an implied market capitalization of up to 12.6 billion francs.